A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Shehab, Habibul Mohsin
مؤلفون آخرون:	Yasmin, Hasina
التنسيق:	أطروحة
اللغة:	English
منشور في:	Brac University 2024
الموضوعات:	Pharmacovigilance Rivastigmine Alzheimer's disease Dementia Pharmacoepidemiology. Mortality. Alzheimer's disease.
الوصول للمادة أونلاين:	http://hdl.handle.net/10361/22683

مواد مشابهة

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
بواسطة: Tabassum, Nadira
منشور في: (2024)

Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
بواسطة: Mahee, Sadique Abdal
منشور في: (2024)

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
بواسطة: Alim, Abdul
منشور في: (2023)

Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
بواسطة: Karmaker, Swastika
منشور في: (2024)

A pharmacovigilance study on Donepezil: signal detection of rhabdomyolysis and death
بواسطة: Jahan, Nusrat
منشور في: (2023)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
بواسطة: Ishrat, Nowshin
منشور في: (2024)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
بواسطة: Bakar, Osama Bin Abu
منشور في: (2024)

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
بواسطة: Chowdhury, Sariya Uzrat
منشور في: (2022)

Role of protein’s and future treatment options for Alzheimer’s Disease
بواسطة: Islam, Md. Irfath
منشور في: (2023)

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
بواسطة: Saha, Bithi Rani
منشور في: (2023)

Alzheimer's disease and marriage : an intimate account /
بواسطة: Wright, Lore K.
منشور في: (1993)

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
بواسطة: Hassan, Md. Muhtaz
منشور في: (2020)

Glymphatic system: a pathway for managing endogenous metabolites in CNS
بواسطة: Tasneem, Sadia
منشور في: (2021)

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
بواسطة: Tamanna, Mst. Taskia
منشور في: (2023)

Emerging therapies of Alzheimer’s disease: a comprehensive review
بواسطة: Tasin, Md Abtahi
منشور في: (2023)

Biomarkers of Alzheimer’s disease: a hope for early diagnosis
بواسطة: Aziz, Farhin
منشور في: (2019)

An ambient assisted living system for Alzheimer’s patients
بواسطة: Abedin, Minhajul, وآخرون
منشور في: (2023)

Prospective detection methods for Tau protein: an important biomarker for Alzheimer’s disease
بواسطة: Afra, Sumaiya
منشور في: (2022)

Marine compounds in the treatment of Alzheimer’s disease
بواسطة: Parveen, Sanjana
منشور في: (2022)

Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
بواسطة: Halim, Rabea
منشور في: (2022)

Exploring the role of programmed cell death protein 1 in alzheimer’s disease associated autoimmunity
بواسطة: Aana, Afsara Sumon
منشور في: (2021)

Exploring Alzheimer's disease prediction with XAI in various neural network models
بواسطة: Rahman, Quazi Ashikur, وآخرون
منشور في: (2022)

Epigenetic dysregulation in neurodegenerative diseases and potential treatment
بواسطة: Mostofa, Golam
منشور في: (2022)

Gene editing for neurodegenerative diseases-A review
بواسطة: Sharna, Anika Islam
منشور في: (2023)

A review on adult neurogenesis in Alzheimer’s disease
بواسطة: Akter, Moriam
منشور في: (2022)

Potential treatments for epigenetic dysregulation in neurological diseases
بواسطة: Zaman, Rubaiyat
منشور في: (2024)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
بواسطة: Haque, Mushfiqul
منشور في: (2019)

Federated GAN based biomedical image augmentation and classification for Alzheimer’s disease
بواسطة: Roy, Aditya, وآخرون
منشور في: (2023)

Investigating the link between Cardiovascular diseases and neurodegenerative disorders
بواسطة: Dey, Manashi
منشور في: (2024)

An efficient deep learning approach for detecting Alzheimer’s disease using brain images
بواسطة: Sani, Mehedi Hasan, وآخرون
منشور في: (2022)

Anti-alzheimer and antioxidant activity of celastrus paniculatus seed
بواسطة: Alam, Badrul, وآخرون
منشور في: (2016)

Role of circular RNA in neurological disease
بواسطة: Salsabil, Labiba
منشور في: (2024)

Design and evaluation of convolutional neural network for detection of Alzheimer’s disease using MRI data
بواسطة: Mahbub, Riasat, وآخرون
منشور في: (2022)

Skeleton /
بواسطة: Parkin, Peter

A review on interrelation among post-authorisation study, regulatory action and pharmacogenetics in pharmacovigilance
بواسطة: Nusrat, Tanzina
منشور في: (2019)

হার্ট, ব্লাড, ফুড /
بواسطة: কাসেম, এম এ

Antihypertensive drugs and risk of cancer: A pharmacovigilance study
بواسطة: Rahman, Ahadina
منشور في: (2018)

Management of Diabetes patients during COVID-19
بواسطة: Pantho, G. M. Golam Mehebub
منشور في: (2021)

Pharmacoepidemiology and pharmacovigilance : synergistic tools to better Investigate drug safety /
بواسطة: Nour, Sabrina
منشور في: (2019)

Detection of alzheimer's disease using deep learning
بواسطة: Hasan, Mahmudul, وآخرون
منشور في: (2021)